Loading clinical trials...
Loading clinical trials...
A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Tipranavir (Aptivus®) Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice.
Conditions
Interventions
Tipranavir
ritonavir
Locations
20
Romania
Boehringer Ingelheim Investigational site 9
Arad, Romania
Boehringer Ingelheim Investigational site 13
Bacau, Romania
Boehringer Ingelheim Investigational site 17
Brasov, Romania
Boehringer Ingelheim Investigational site 18
Brasov, Romania
Boehringer Ingelheim Investigational site 19
Brasov, Romania
Boehringer Ingelheim Investigational site 1
Bucharest, Romania
Start Date
September 1, 2009
Primary Completion Date
July 1, 2011
Completion Date
July 1, 2011
Last Updated
March 20, 2014
NCT04142047
NCT06694805
NCT07428330
NCT07225530
NCT06665646
NCT05897099
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions